Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer
Adoptive cell therapy (ACT) is one of promising immunotherapies for cancer patients by providing a large amount of cancer antigen-specific effector T cells that can be manufactured rapidly by ex vivo gene engineering. To provide antigen-specificity to patients’ autologous T cells in a short-term cul...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis Group
2022-12-01
|
| Colección: | OncoImmunology |
| Materias: | |
| Acceso en línea: | http://dx.doi.org/10.1080/2162402X.2021.2020983 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|